insights_auto
Why is MBIO down 2.24%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
$0.52
arrow_downward
-2.24%(-0.012) 1D
$0.52
0.00% (0.00)
todayPre-market
Closed: Sep 25, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.52
High
$0.52
Low
$0.52
Mkt. cap
3.92M
Avg. vol.
23.24K
Volume
0.00
52-wk high
$1.84
52-wk low
$0.47
EPS
-$0.46
Beta
2.05
Shares outstanding
6.73M
No. of employees
4
Open
$0.52
High
$0.52
Low
$0.52
Mkt. cap
3.92M
Avg. vol.
23.24K
Volume
0.00
52-wk high
$1.84
52-wk low
$0.47
EPS
-$0.46
Beta
2.05
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 months ago
MBIO Q4 2024 Earnings: Significant EPS Miss Amid Pre-Revenue Biotech Operations - Book Value Growth
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com